Pulmatrix
PULM
$1.92
Share price
1.47%
Change (1 day)
-30.77%
Change (1 year)
Categories
Pulmatrix (PULM) - Cash on Hand
Cash on Hand as of March 2024 : $16.3 M
According to Pulmatrix's latest financial reports the company has $16.3 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Pulmatrix - Cash on Hand chart (from 2013 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $35.62 M | -33.83% |
| 2021-12-31 | $53.84 M | 70.07% |
| 2020-12-31 | $31.65 M | 35.06% |
| 2019-12-31 | $23.44 M | 814.55% |
| 2018-12-31 | $2.56 M | -27.8% |
| 2017-12-31 | $3.55 M | -15.11% |
| 2016-12-31 | $4.18 M | -77.88% |
| 2015-12-31 | $18.9 M | |
| 2015-03-31 | $10.35 M | -33.49% |
| 2014-03-31 | $15.57 M | 16119.79% |
| 2013-03-31 | $0.09 M | |
| 2012-03-31 | $N/A |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Pieris Pharmaceuticals PIRS | $19.08 M | 17.08% | 🇺🇸 USA |
 OPKO Health
OPK | $75.63 M | 364.04% | 🇺🇸 USA |
 Blueprint Medicines
BPMC | $0.64 B | 3,874.85% | 🇺🇸 USA |